Sign in

CIK 0001665988

  • Accelerated filer
  • Emerging growth company

Bioventus Inc.

Sign in to watch
Ticker
BVS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
810980861
Phone
+1 919-474-6700
Business address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
  1. 4 Open-market sale Chief Executive Officer sold 9,811 shares at $1.39 ($13,625)
  2. 4 Open-market sale SVP & Chief Compliance Officer sold 1,332 shares at $1.39 ($1,850)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Exercise or conversion Director acquired 965 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Exercise or conversion Director acquired 965 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 385 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 1,813 shares (option exercise)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Director acquired 2,780,923 shares (grant or award)
  15. 4 Exercise or conversion Director acquired 40,573 shares (option exercise)
  16. 4 Open-market sale SVP & General Counsel sold 16,016 shares at $11.19 ($179,238)
  17. 4 Open-market sale Chief Commercial Officer sold 65,963 shares at $11.12 ($733,502)
  18. 4 Exercise or conversion Director acquired 2,700 shares (option exercise)
  19. 4 Exercise or conversion Director acquired 2,700 shares (option exercise)
  20. 4 Exercise or conversion Director acquired 2,700 shares (option exercise)

Page 9 of 13 · 251 filings